Educational Grants

Grants

Educational Grants

Promius® Pharma, a subsidiary of Dr. Reddy’s Laboratories, supports independent medical education programs that provide nonpromotional medical and scientific education to health care providers (HCPs). The intent of these programs is to improve patient care through HCP education. All such programs must be compliant with applicable legal and regulatory guidelines.

Through our Educational Grant program, Promius Pharma helps address the clinical practice gaps that exist in the diagnosis, management, and prevention of certain diseases. Promius Pharma also supports patient education through educational grants to patient advocacy groups.

Therapeutic Areas of Interest for Educational Grants

The Promius Pharma Educational Grants Office will accept and review educational grant requests in the following therapeutic areas:

Neurology

  • Migraine – Adult
  • Parkinson’s Disease
  • Epilepsy

Dermatology

  • Medical Dermatology

Note: For any supported non-accredited educational activity intended for health care providers and for education intended for patients and/or caregivers, any discussion of Promius Pharma products must be within approved product labeling and fairly balanced.

Activities Considered for Funding

The Promius Pharma Educational Grants Office will consider educational grant applications for the following types of activities aimed at improving patient care through the advancement of HCP education.

  • Independent educational activities taking place within the United States or providing substantial educational activities applicable to US clinical practice.
  • CE-accredited or non-accredited, nonpromotional educational activities
  • Activities scheduled to occur at least 90 days after the date of submission of a complete educational grant request
  • Activities providing significant independent, nonpromotional, scientific education within Promius Pharma therapeutic areas of interest
  • Activities held at venues appropriate for the provision of independent, nonpromotional education without significant distraction
  • Activities designed for the nonpromotional education of HCPs, including physicians, medical fellows, medical residents, medical interns, medical students, nurses, physician’s assistants, and/or other health professionals
  • Activities whose faculty has been selected by the conference organizers completely independently of commercial sponsors
  • Activities whose educational content has been developed by the conference faculty completely independently of commercial sponsors

Types of grants not considered for funding

Promius Pharma will NOT provide medical education grants for the following:

  • Individual HCPs or HCP private practice groups
  • Health plans or managed care organizations
  • Grant requestors who have received past funding but have not adequately completed educational grant reconciliation within the specified time frame
  • Grant requestors who have received past funding but have not returned unused grant funds within the specified time frame
  • Activities that are intended to directly or indirectly promote Promius Pharma products
  • Events in which there are recreational components (eg, golf or spa activities)
  • Events which include gifts to speakers or attendees
  • Activities that have already occurred or are in process
  • Research or training within a medical institution
  • Clinical research or investigator-initiated trials
  • Charitable contributions
  • Service contracts
  • Promotional exhibit or display fees
  • Combined funding for educational and promotional activities
  • Events that do not have an educational focus
  • Professional or business development activities
  • Travel, lodging, meals, or registration for any HCP to attend a meeting or event, if that HCP is not part of the program faculty. Funding for faculty accommodation should be commensurate with the actual duration of time that the HCP is required to participate in a multi-day event.
  • Entertainment (eg, recognitions, retirement dinners, holiday parties)
  • Capital or operating expenses (eg, purchase of equipment, salary staff)
  • Funding of promotional exhibits or display space
  • Journal clubs
  • Textbooks or Equipment

Guidelines and Regulations

The Promius Pharma grant approval process is in accordance with the recommendations and guidance of the Office of Inspector General (OIG), Pharmaceutical Research and Manufacturers of America (PhRMA), the Accreditation Council for Continuing Medical Education (ACCME), National Physician Payment Transparency Program: Open Payments (commonly known as the Sunshine Act), and internal Promius Pharma compliance policies.

Promius Pharma only provides independent educational grants based on the scientific and educational merit of the proposed activity. No educational grants shall be provided or offered to a health care professional in exchange for prescribing products or for a commitment to continue prescribing products. Nothing should be offered or provided in a manner that would interfere with the independence of a health care professional’s prescribing practices or decision-making.

Prohibited Actions

  • Promius Pharma Sales and Marketing representatives may not facilitate applications for educational grant funding, request or convey educational grant status information on behalf of or to applicants, or submit or review applications for educational grant funding. Submission of grant requests by any Promius Pharma personnel will result in automatic rejection of the request.
  • An educational grant may never be made with the intent to induce referrals for the purchase, prescribing, dispensing, or recommending of Promius Pharma products or to influence the position of any Promius Pharma product on a managed care formulary or generic program.
  • Promius Pharma employees cannot provide any advice or guidance to an individual or organization requesting an educational grant regarding the content, faculty, educational methods, materials, venue, or any other matter related to the educational event.
  • Promius Pharma cannot directly or indirectly fund a health care professional’s travel, lodging, or personal expenses related to attending an educational event as a non-faculty participant.
  • Educational Grants may not be used to directly or indirectly fund a Healthcare Professional’s travel, lodging, or personal expenses related to attending an educational event, however grant funding can be used to cover the costs of faculty participation or to provide scholarship funds to enable a health care professional in training to attend an educational event.
  • If the requesting organization uses the educational grant as a scholarship or other educational funding to enable a healthcare professional in training to attend an educational event, the organization must independently select the recipient(s).
  • Promius Pharma cannot directly or indirectly compensate any health care professional for attending an educational event; however, grant funding can be used to cover the costs associated with faculty participation.
  • Promius Pharma educational grant funds may not be used to provide food or beverage to attendees at educational events. However, Promius Pharma grant funding can be used to cover the costs associated with faculty participation (eg, compensation, travel, meals). If food and beverage are provided for participants at educational events supported by Promius Pharma educational grant funding, the cost for these must be covered by alternative funding or participant registration fees (ie, not Promius Pharma educational grant funding) and ACCME guidelines should be followed, in that meals should be modest and not be the primary focus of the gathering of HCPs.

Reconciliation of Completed Grants

Promius Pharma requires reconciliation of all educational grants within 90 days of the activity end date. The purpose of the reconciliation is to verify that the grant support was used in the manner in which it was intended. At the conclusion of the Promius Pharma funded activity, the grant recipient is required to submit the following information:

  • Summary of participants/audience reach
  • Evaluation data or other information to verify that grant funds were used as described in the Educational Grant application
  • Financial reconciliation
  • HCP payment Sunshine Act reporting

If educational grant reconciliation is not received within 90 calendar days of the activity end date, grant support applications will not be accepted from your organization until this reconciliation has been received. Promius Pharma reserves the right to request receipts to support the activity expenses specified in the grant reconciliation.

NOTE: All unused funds must be returned to Promius Pharma within 90 days of the activity end date. Educational grant recipients are not permitted to redirect funds for purposes not specified in the original grant application.

National Physician Payment Transparency Program: Open Payments

On February 8, 2013 the Centers for Medicare & Medicaid Services (CMS) published the final rule to implement section 6002 of the Affordable Care Act (now known as the National Physician Payment Transparency Program: Open Payments [commonly referred to as the Sunshine Act]). Promius Pharma captures and submits to the CMS all payments and other Transfers of Value (TOV) made to physicians and Teaching Institutions (TIs) annually. Promius Pharma requires all recipients of educational grant funding to report any non excluded TOV made to Covered Recipients (CRs).

Activities that meet the accreditation or certification requirements and/or standards for Continuing Education of one of the following: ACCME, AOA, AAFP, and AMA, do not require additional reporting.

Additional reporting is required for activities that do not meet the accreditation or certification requirements and/or standards of ACCME, AOA, AAFP, and AMA, including all indirect payments (faculty compensation, travel, meals) to all CRs associated with this activity.

The following information is required to be reported to Promius Pharma within 90 calendar days of the activity end date including, but not limited to:

  • CR type: physician or TI
  • CR full name
  • Complete business address
  • National Provider Identifier (NPI) number and/or license number
  • Specialty (if applicable)
  • Form of payment or transfer of value
  • Nature of payment or transfer of value

To obtain the Promius Pharma Sunshine reporting form or for questions about Sunshine Act reporting related to Promius Pharma educational grant funding, email:

mededgrants@promiuspharma.com

For questions regarding the National Physician Payment Transparency Program: Open Payments (commonly known as the Sunshine Act) ›

Required Application Documents

A complete application package consists of the following:

  • Letter of Request on requesting organization letterhead
  • Promius Pharma Grant Certification Form
  • Program description
  • Learning objectives and proposed agenda
  • Information describing CE accreditation, if applicable
  • Budget, including the overall cost of the program and a breakout of detailed line items
  • W-9
  • Additional supporting documentation (eg, educational needs assessment, description of venue)

If your grant application is approved, the authorized signer identified in your application will receive an electronic Educational Grant Agreement for review and signature. A signed copy of this Educational Grant Agreement must be returned to Promius Pharma at the mededgrants@promiuspharma.com email address before the approved grant payment can be processed.

Promius Pharma does not accept third party Letters of Agreement. Promius Pharma educational grant funding is contingent upon authorized signers’ execution of the Promius Pharma Educational Grant Agreement.

Disclosure of Grant Support

Promius Pharma educational grant support must be disclosed prior to the start of the supported educational activity. The disclosure should take the form: “Supported by an educational grant from Promius Pharma” or similar disclosure. The Promius Pharma company logo will be provided upon request. Please reference your educational grant application number when requesting a copy of our company logo.

Promius Pharma reserves the right to publicly disclose the grant recipient organization name, event title and description, payee state, and grant amount awarded.

How to Apply for a Promius Educational Grant

No mailed or faxed applications will be accepted. All educational grant applications must be submitted to:

mededgrants@promiuspharma.com

Educational grant applications will not be accepted for review until they are complete. When a completed application has been received, you will receive an acknowledgement containing a unique application number. Please reference this number when corresponding about your grant application.

In order to be accepted for review, complete educational grant applications must be received at least 90 days before the start of an educational activity.

Download the Promius Pharma Educational Grant Certification Form ›

Contact Us

For questions, additional information, or submission of educational grant request materials, please use the following email address:

mededgrants@promiuspharma.com